Kawita M S Kanhai (K M S Kanhai)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Multiple Sclerosis

Gas Chromatography

Top Venues

British journal of clinical pharmacology

Clinical and translational science

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Francis M Dijkstra, Rob G J A Zuiker, Jules A A C Heuberger, Kawita M S Kanhai, Marieke De Kam, Thierry Duvauchelle, Jeanne-Marie Lecomte, Olivier Labeeuw, Laurent Landais, Xavier Ligneau, Philippe Robert, Marc Capet, Jean-Charles Schwartz, Joop M A van Gerven
Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist in healthy male volunteers: central nervous system depression and pseudo-hallucinations. British journal of clinical pharmacology (2023)
Kawita M S Kanhai, Sebastiaan C Goulooze, Jeroen van der Grond, Amy C Harms, Thomas Hankemeier, Ajay Verma, Gersham Dent, Juan Chavez, Henri Meijering, Geert Jan Groeneveld
Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis. Clinical and translational science (2021)
Kawita M S Kanhai, Jenny A Nij Bijvank, Yorick L Wagenaar, Erica S Klaassen, KyoungSoo Lim, Sandrin C Bergheanu, Axel Petzold, Ajay Verma, Jacob Hesterman, Mike P Wattjes, Bernard M J Uitdehaag, Laurentius J van Rijn, Geert Jan Groeneveld
Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial. CNS neuroscience & therapeutics 25 (6) (2019)
Kawita M S Kanhai, R G J A Zuiker, I Stavrakaki, W Gladdines, P J Gaillard, E S Klaassen, G J Groeneveld
Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study. British journal of clinical pharmacology 84 (5) (2018)